title: Right ventricle: wrong targets? Another blow for pharmacotherapy in congenital heart diseases.
authors.forename: S Lucy
authors.initials: SL
authors.lastname: Roche
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Redington
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology*; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects* / Q000503:physiopathology*; D006801:Humans; D008297:Male; D013318:Stroke Volume / Q000187:drug effects* / Q000502:physiology*; D013777:Tetrazoles / Q000494:pharmacology*; D014633:Valine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000068756:Valsartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine